SCM
OKYO

Stonepine Capital Management’s OKYO Pharma OKYO Stock Holding History

Stonepine Capital Management’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.37M Buy
+850,000
New +$1.65M 0.55% 30

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Stonepine Capital Management's OKYO Position: Q1 2026 in Review

Stonepine Capital Management opened a new position in OKYO Pharma (OKYO) in Q1 2026: 850,000 shares worth $1.37M. The stake represents 0.55% of the portfolio and ranks #30 among its holdings.

12 funds tracked by Wall St. Rank hold OKYO as of Q1 2026.

  • Stonepine Capital Management held 850,000 shares of OKYO Pharma worth $1.37M as of Q1 2026.
  • OKYO Pharma was a new Stonepine Capital Management position in Q1 2026.
  • OKYO Pharma made up 0.55% of Stonepine Capital Management's portfolio in Q1 2026, its #30 holding.
  • 12 funds tracked by Wall St. Rank held OKYO Pharma as of Q1 2026.

Based on Stonepine Capital Management's 13F filing for Q1 2026, filed 14 May 2026.